PeptidePicker
RecoveryResearch

GLP-2

Also known as: Glucagon-like peptide 2

A gut-trophic peptide that promotes intestinal mucosal growth and repair. Studied for short bowel syndrome and inflammatory bowel disease.

Dr. Sarah Mitchell

Reviewed by Dr. Sarah Mitchell, PharmD, BCPS

Lead Researcher · 12+ years in peptide therapeutics

Half-Life

~7 minutes (native)

Typical Dose

Research dosing

Administration

Subcutaneous injection

Mechanism of Action

Activates GLP-2 receptors on subepithelial myofibroblasts to stimulate crypt cell proliferation, increase villus height, and enhance nutrient absorption.

Key Research Areas

gutintestinalrepairIBD

Frequently Asked Questions

What is GLP-2?
A gut-trophic peptide that promotes intestinal mucosal growth and repair. Studied for short bowel syndrome and inflammatory bowel disease.
How does GLP-2 work?
Activates GLP-2 receptors on subepithelial myofibroblasts to stimulate crypt cell proliferation, increase villus height, and enhance nutrient absorption.
What is the recommended dosage for GLP-2?
The typical research dosage is Research dosing, administered via Subcutaneous injection. Dosage protocols vary by study and should be determined by a qualified healthcare professional.
What is the half-life of GLP-2?
The half-life of GLP-2 is approximately ~7 minutes (native). This affects dosing frequency and timing in research protocols.
Is GLP-2 FDA approved?
GLP-2 is currently classified as "Research" and is not FDA approved for general use. It is available for research purposes or through compounding pharmacies depending on your jurisdiction.

Research Disclaimer

The information provided about GLP-2 is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.

Related Peptides in Recovery